EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-albicans Candida and rare yeasts in vulvovaginal candidiasis: pathogen attribution, antifungal resistance, persistence, and species-informed management

Ziyi Yan, Yali Cui, Yingying Li, Xue Xiao, Meng Liao, Xingxin Liu, Wei Zhou, Linghan Kuang, Yongmei Jiang

Frontiers in Microbiology · 09.09.2026 · 17

DOI: 10.3389/fmicb.2026.1944046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.09.2026. Verfasst von Ziyi Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvovaginal candidiasis (VVC) is usually attributed to Candida albicans ( C. albicans ), but non- albicans Candida species and rare yeasts are increasingly encountered in recurrent, complicated, or treatment-refractory disease. Their clinical significance is not uniform: some isolates represent causative infection, whereas others reflect colonization, mixed vaginitis, or detection without causality. This Mini Review addresses three linked clinical and biological questions. First, pathogen attribution should move from detection to causative diagnosis. Recurrent or refractory symptoms warrant structured reassessment during an active episode, integrating clinical examination, vaginal pH and microscopy, fungal culture with species-level identification, exclusion of competing diagnoses, and susceptibility testing when indicated. Second, persistence differs from the C. albicans paradigm and may involve niche adaptation, epithelial association, biofilm-associated tolerance, stress survival, and species-dependent relationships between susceptibility phenotypes and persistence-associated traits. Third, management should be species-informed and susceptibility-aware: Nakaseomyces glabratus (formerly Candida glabrata ) and Candida krusei/Pichia kudriavzevii require different salvage-treatment logic, whereas evidence for uncommon Candida species and rare yeasts remains limited and case-based. New antifungals have promising activity, but current trials do not establish species-specific efficacy in non- albicans VVC. Probiotics and microbiome-directed interventions should remain investigational adjuncts evaluated in strain-defined, species-stratified trials rather than substitutes for antifungal therapy. We further identify limitations in the evidence base and priorities for vaginally relevant epithelial, immune-cell, and polymicrobial models. Integrating causative attribution with resistance, tolerance, and persistence biology may reduce both undertreatment of clinically attributable infection and overtreatment of colonization or noninfectious vulvovaginal disease.

Schlagwörter

Stichwörter der Autor:innen

CandidaCandida glabrataNakaseomyces glabratusSaccharomyces cerevisiaerecurrent vulvovaginal candidiasisvulvovaginal candidiasis

Autor:innen und Institutionen

  • Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Department of Laboratory Medicine, West China Second University Hospital (Tianfu), Sichuan University (Sichuan Provincial Children's Hospital), Meishan, China.
  • Department of Laboratory Medicine, Meishan Women and Children's Hospital, Alliance Hospital of West China Second University Hospital, Sichuan University, Meishan, China.
  • Department of Laboratory Medicine, Women and Children's Hospital of Tibet Autonomous Region, Lhasa, China.
  • Department of Laboratory Medicine, Chengdu Hi-Tech Zone Hospital for Women and Children (Chengdu Hi-Tech Zone Hospital for Maternal and Child Healthcare), Chengdu, China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.

Zitieren

APA

Yan, Z., Cui, Y., Li, Y., Xiao, X., Liao, M., Liu, X., Zhou, W., Kuang, L., & Jiang, Y. (2026). Non-albicans Candida and rare yeasts in vulvovaginal candidiasis: pathogen attribution, antifungal resistance, persistence, and species-informed management. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1944046

Vancouver

Yan Z, Cui Y, Li Y, Xiao X, Liao M, Liu X, et al. Non-albicans Candida and rare yeasts in vulvovaginal candidiasis: pathogen attribution, antifungal resistance, persistence, and species-informed management. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1944046

BibTeX
@article{Yan2026,
  author = {Yan, Ziyi and Cui, Yali and Li, Yingying and Xiao, Xue and Liao, Meng and Liu, Xingxin and Zhou, Wei and Kuang, Linghan and Jiang, Yongmei},
  title = {Non-albicans Candida and rare yeasts in vulvovaginal candidiasis: pathogen attribution, antifungal resistance, persistence, and species-informed management},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1944046}
}
Kostenlos starten →